Antimicrobials

Navigating the COVID-19 Pandemic for Participant Recruitment and Follow-up: Experiences from the PediCAP Clinical Trial Consortium

30 Nov, 2023

Authors: Kiggwe A, Nalwanga D, Tagoola A, Madhi S, Moore PD, Archary M, Mulenga V, Mujuru AH, Sacarlal J, Buck WC, Sidat M, Nguyen H, Haque F, Dennis E, Clements…
Read More

External factors affecting recruitment in a global paediatric pneumonia trial: lessons learned from PediCAP

28 Nov, 2023

Authors: Pillay K, Archary M, Bielicki J, Buck WC, Clements M, Dennis E, Goelen J, Haque F, Kiggwe A, Madhi S, Moore PD, Mujuru AH, Mulenga V, Murphy B, Musiime…
Read More

Building a national network for inpatient pediatric clinical research in Mozambique 

28 Nov, 2023

Authors: Sacarlal WJ, Buck C, Passanduca A, Macassa E, Saíde A, Chhaganlal K, Gafur M, Seni A, Machava S, Martins L, Issa F, Macanze E, Manjate N, Chaúque S, Langa…
Read More

Receipt of intravenous co-amoxiclav challenged eligibility screening for the PediCAP Trial in Johannesburg, South Africa 

28 Nov, 2023

Authors: Moore PD, Waggie Z, Nkosi S, Nkosi L, Kumalo N, Nkumana N, Zulu N, Dangor Z, Sharland M, Madhi S Presented at: The EDCTP Forum 2023
Read More

Kangaroo care as a potential infection prevention and control (IPC) measure in neonatal intensive care units

13 May, 2023

Authors: Schlaeppi C, Bielicki J, and the NeoIPC Consortium. Presented at: ESPID 2023
Read More

Infection prevention and control practices in neonatal units participating in the NeoIPC project

18 Apr, 2023

Authors: Schlaeppi C, Bielicki J, and the NeoIPC Consortium Presented at: ECCMID 2023
Read More

Implementation of infection prevention and control for hospitalised neonates: A narrative review

12 Dec, 2022

Authors: Nyantakyi E, Caci L, Castro M, Schlaeppi C, Cook A, Albers B, Walder J, Metsvaht T, Bielicki J, Dramowski A, Schultes MT, Clack L Published in: Clinical Microbiology and…
Read More

Antibiotics needed to treat multidrug-resistant infections in neonates

24 Nov, 2022

Authors: CM Williams PCM, Qazi SA, Agarwal R, Velaphi S, Bielicki JA, Nambiar S, Giaquinto C, Bradley J, Noel GJ, Ellis S, O’Brien S, Balasegaram M & Sharland M Published in:…
Read More

Optimised versus standard dosing of vancomycin in infants with Gram-positive sepsis (NeoVanc): a multicentre, randomised, open-label, phase 2b, non-inferiority trial

03 Dec, 2021

Authors: Hill L.F, Clements M.N, Turner M.A, Donà D, Lutsar I, Jacqz-Aigrain E, Heath P.T, Roilides E, Rawcliffe L, Alonso-Diaz C, Baraldi E, Dotta A, Ilmoja M, Mahaveer A, Metsvaht…
Read More

Global estimates of the relative pediatric consumption and cost of oral amoxicillin and amoxicillin plus clavulanic acid

20 Jul, 2021

Authors: G. A. Levine, M. Sharland, S. Ellis, Y. Ferrisse, C. Loze, Y. Hsia, G. Fink, J. Bielicki; for the PediCAP project Published in: ECCMID 2021   Abstract Background: Amoxicillin…
Read More

Harmonising regulatory approval for antibiotics in children

21 Jan, 2021

Authors: Phoebe C M Williams, John Bradley, Emmanuel Roilides, Linus Olson, Sheldon Kaplan, Irja Lutsar, Carlo Giaquinto, Daniel K Benjamin, Mike Sharland Published in: The Lancet Introduction: Antimicrobial resistance represents a substantial…
Read More

Global sales of oral antibiotics formulated for children

02 Jul, 2020

Authors: Li G, Jackson C, Bielicki J, Ellis S, Hsiac Y, Sharland M Published in: Bulletin of the World Health Organization, July 2020 Objective To investigate international consumption patterns of…
Read More

A comparison of five paediatric dosing guidelines for antibiotics

28 Apr, 2020

Authors: Mathur S, Jackson C, Urus H, Ziarko I, Goodbun M, Hsia Y, Ellis S, Sharland M. Published in: Bulletin of the World Health Organization, April 2020 Objective To compare…
Read More

Interim pharmacokinetic analysis of a multi-centre randomised open label phase IIb study in neonates to validate the meta-analysis population pharmacokinetic model used to simulate an optimised dosing regimen in neonates and infants aged < 90 days: the NeoVanc trial

26 Apr, 2020

Authors: L. Hill, E. Jacqz-Aigrain, V. Elie, W. Zhao, M. Clements, M. Turner, I. Lutsar, P. Heath, E. Roilides, S. Walker, M. Sharland Published in: 30th European Congress on Clinical…
Read More

An optimised dosing regimen vs. a standard dosing regimen of vancomycin for the treatment of late onset sepsis due to Gram-positive microorganisms in infants less than 90 days: the NeoVanc trial

26 Apr, 2020

Authors: L. Hill, M. Clements, M. Turner, I. Lutsar, E. Jacqz-Aigrain, P. Heath, E. Roilides, S. Walker, M. Sharland Published in: 30th European Congress on Clinical Microbiology and Infectious Diseases…
Read More
1 2 3